These results profoundly indicate that FFAR2 signaling regulates GLP-1 and PYY secretion and may pave the way to consider FFAR2 as a therapeutic target against diabetes, because GLP-1 increase is beneficial in regulation of blood glucose levels. This evidence concerns the gene GCG and diabetes mellitus.